Carregant...

Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy

STUDY QUESTION: Among women who carry pathogenic mitochondrial DNA (mtDNA) point mutations and healthy oocyte donors, what are the levels of support for developing oocyte mitochondrial replacement therapy (OMRT) to prevent transmission of mtDNA mutations? SUMMARY ANSWER: The majority of mtDNA carrie...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Reprod
Autors principals: Engelstad, Kristin, Sklerov, Miriam, Kriger, Joshua, Sanford, Alexandra, Grier, Johnston, Ash, Daniel, Egli, Dieter, DiMauro, Salvatore, Thompson, John L.P., Sauer, Mark V., Hirano, Michio
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840023/
https://ncbi.nlm.nih.gov/pubmed/26936885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/humrep/dew033
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!